The small molecule SHH inhibitor RUSKI-43 effectively suppresses cell proliferation, migration, and invasion in endometrial cancer cells lacking functional SPOP or expressing endometrial cancer -associated SPOP mutants 116, underscoring its potential as a therapeutic strategy in SPOP-deficient endometrial cancer. The gene discussed is SHH; the disease is endometrial cancer.